Patent Assignment
Reel/Frame 051653/0879
Assignment of Assignor's Interest
Recorded: 2019-12-17
Pages: 4
Assignors
FUKUSHIMA, MASAYOSHI
Executed: 2011-12-27
ORITA, KAZUHIRO
Executed: 2011-12-27
YAMANE, SHOGO
Executed: 2011-12-27
Assignee
JAPAN TOBACCO INC.
2-1 TORANOMON 2-CHOME, MINATO-KU, TOKYO, 105-8422, JAPAN
Covered Property
(1)
Tablet Containing Ferric Citrate
Application:
16/438,694 →
Publication:
US 2020/0163890
Related Assignments
(9)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Apr 2, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 052295/0662 →
Second Amended and Restated Intellectual Property Security Agreement
Sep 2, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 053671/0221 →
Third Amended and Restated Intellectual Property Security Agreement
Sep 10, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 054173/0451 →
Fourth Amended and Restated Intellectual Property Security Agreement
Dec 17, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 054793/0455 →
Fifth Amended and Restated Intellectual Property Security Agreement
Mar 30, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 055776/0491 →
Change of Address
Apr 9, 2021
From: JAPAN TOBACCO INC.
To: JAPAN TOBACCO INC.
Reel/Frame 056797/0633 →
Sixth Amended and Restated Intellectual Property Security Agreement
Jun 11, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 056544/0468 →
Termination and Release of Security Interest in Patents
Jan 29, 2024
From: BIOPHARMA CREDIT PLC
To: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 066377/0741 →
Termination and Release of Security Interest in Patents
Jun 25, 2024
From: BIOPHARMA CREDIT PLC
To: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 067839/0134 →